Supio
How Hype Index is computed Β· prospect-to-user intent ratio over the 12-month window
What it is
What It Does
Supio is a Seattle-based AI platform for personal injury and mass-tort litigation. It helps plaintiff firms organise, analyse, and prepare cases β ingesting and structuring large volumes of case data such as medical and billing records to support case preparation. It integrates with case-management systems including Litify and SmartAdvocate, and with Westlaw.
What We Found
Supio raised a $25M Series A (led by Sapphire Ventures, announced August 2024) and a $60M Series B in May 2025, again led by Sapphire with Mayfield and Thomson Reuters Ventures participating β bringing total funding to roughly $91M. It reports 4x ARR growth since emerging from stealth and was about a 100-person company at the Series B, with plans to roughly double headcount. Thomson Reuters has a published partnership with Supio for personal injury firms. Coverage appears in LawSites, GeekWire, and Maginative.
Who Itβs For β Persona Workflows
Plaintiff PI / Mass-Tort Firm
ββββββββββββββββββββββββββββ
Workflow fit: Case intake β records review / analysis β case preparation
Strengths: Structures large medical/billing record sets; integrates with
Litify and SmartAdvocate; Thomson Reuters partnership.
Gaps: Narrowly scoped to PI / plaintiff work β not a general firm platform.
In-House / Corporate Legal
ββββββββββββββββββββββββββ
Workflow fit: Not designed for in-house or corporate work. Skip this one.
What We Havenβt Verified
- The β4x ARR growthβ figure β vendor-stated
- Pricing (not published)
- Real-world accuracy of records extraction in production use
Integrations
Platforms Supio integrates with. Depth β where curated β reflects how native the connection is. Uncurated entries render without a depth dot.
- Litify
- SmartAdvocate
- Westlaw
Deep β bi-directional API Medium β one-way sync / webhook Shallow β middleware / Zapier-class
Community ratings
- 2025-06DeMayo Law Offices β Personal injury firm COO detailed its AI rollout in partnership with Supiosource β